SCHEMBL19917

SCHEMBL19917

COc1[c]cc(Cl)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9111454 0.77 PTPN1 (0.32) —
SCHEMBL159912 0.76 ADRB2 (0.31) —
SCHEMBL162984 0.76 NQO1 (0.36) —
SCHEMBL359290 0.76 HTR2C (0.35) —
SCHEMBL358869 0.74 KDM4E (0.36) —
SCHEMBL105204 0.73 CA1 (0.48) —
SCHEMBL160506 0.73 — —
SCHEMBL9652575 0.73 MAOA (0.45) —
SCHEMBL3958751 0.73 TTR (0.36) —
SCHEMBL24397 0.73 CA1 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3194 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024120442-A1 PAK4 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS CONVERGEN (SUZHOU) PHARMACEUTICAL CO., LTD. (CN) 2024-06-13 — — WO claimed
US-11987588-B2 Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto ARENA PHARMACEUTICALS, INC. (US) 2024-05-21 — — US claimed
CN-118055930-A Thiadiazole derivative, composition and application thereof 北京丹擎医药科技有限公司 2024-05-17 — — CN claimed
US-20230183248-A1 PYRROLO[1,2-D][1,2,4]TRIAZINE-2-YL-ACETAMIDES AS INHIBITORS OF THE NLRP3 INFLAMMASOME PATHWAY JANSSEN PHARMACEUTICA NV (BE) 2023-06-15 — — US claimed
EP-3720858-B1 MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR USEFUL FOR THE TREATMENT OR PREVENTION OF HEART FAILURE AND DISORDERS RELATED THERETO ARENA PHARM INC (US) 2023-06-07 — — EP claimed
WO-2023061415-A1 THIADIAZOLYL DERIVATIVES, COMPOSITIONS AND USES THEREOF DANATLAS PHARMACEUTICALS CO., LTD. (CN) 2023-04-20 — — WO claimed
EP-4135842-A1 PYRROLO[1,2-D][1,2,4]TRIAZINE-2-YL-ACETAMIDES AS INHIBITORS OF THE NLRP3 INFLAMMASOME PATHWAY JANSSEN Pharmaceutica NV (BE) 2023-02-22 — — EP claimed
CN-115485026-A Pyrazolo [1,2-D ] [1,2,4] triazin-2-yl-acetamides as NLRP3 inflammatory pathway inhibitors 詹森药业有限公司 2022-12-16 — — CN claimed
US-20220396579-A1 MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR USEFUL FOR THE TREATMENT OR PREVENTION OF HEART FAILURE AND DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. 2022-12-15 — — US claimed
CN-107879975-B Histone deacetylase inhibitor and application thereof 中国科学院上海药物研究所 2022-07-26 — — CN claimed
US-4696675-A Process for preparing water-insoluble blue azo dyes on the fiber: hydroxynaphthoic amide and diazotized di-alkoxy-benzidine HOECHST AKTIENGESELLSCHAFT (DE) 1987-09-29 — — US claimed
EP-0199973-A2 Process for the production on the fibre of water insoluble azo dyes HOECHST AKTIENGESELLSCHAFT (DE) 1986-11-05 — — EP claimed
EP-0091193-B1 ANTIDIABETIC COMPOSITIONS PFIZER INC. (US) 1986-05-21 — — EP claimed
EP-0091193-A2 Antidiabetic compositions PFIZER INC. (US) 1983-10-12 — — EP claimed
US-4159983-A Pure and substantially pure asymmetric 1:2 cobalt complexes of monoazo compounds SANDOZ LTD. (CH) 1979-07-03 — — US claimed
US-4051156-A N-(triaryl-methyl)-amidines, process for the preparation thereof and compositions containing the same CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT (HU) 1977-09-27 — — US claimed
US-4041036-A NAPHTHO(1',2':5,6)-PYRANO(2,3-D)PYRIMIDINE DYES HOECHST AKTIENGESELLSCHAFT (DT) 1977-08-09 — — US claimed
US-4029666-A Benzenesulfonyl-ureas and process for preparing them HOECHST AKTIENGESELLSCHAFT (DT) 1977-06-14 — — US claimed
US-3953449-A ANALGESICS SYNTHELABO (FR) 1976-04-27 — — US claimed
US-3932503-A Benzenesulfonyl ureas HOECHST AKTIENGESELLSCHAFT (DT) 1976-01-13 — — US claimed
Send feedback